UTHR
UTHR
NASDAQ · Biotechnology

United Therapeutics Corp

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$497.59
+4.49 (+0.91%)
As of Sep 22, 9:39 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 18 82%
Hold 4 18%
Sell 0 0%
Price Target
Analyst Price Target -82.2% upside
Low Target $65.70
Average Target $88.53
High Target $121.74
Current Price $497.59
Current
$497.59
Target
$88.53
$65.70 $88.53 avg $121.74
Scenario Analysis
Bear Case
$65.70
-86.8%
Low target
Base Case
$88.53
-82.2%
Avg target
Bull Case
$121.74
+-75.5%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$609.35
-18.3% from high
52-Week Low
$397.97
+25.0% from low
50-Day SMA
$485.49
+2.5% vs SMA
200-Day SMA
$394.55
+26.1% vs SMA
RSI (14)
60.3
Neutral
Target vs 52W High
$88.53
-85.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.8%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -53.0%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +141.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -18.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -63.8%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.3%